Target intelligence / Profile preview

Oral biofilm extracellular matrix protein (EPS protein)

Target
EPS protein
Molecular classification
Enzyme, Other
01

Overview

Oral biofilm extracellular matrix proteins are a diverse group of proteins secreted by oral bacteria that constitute a significant portion of the extracellular polymeric substance (EPS) in dental plaque. These proteins, including enzymes like glucosyltransferases (Gtfs) and various adhesins (e.g., AgI/II), play a critical role in the structural integrity and biochemical environment of the biofilm (Bowen et al., 2018, JDR). They facilitate the adhesion of bacteria to the tooth surface and to each other, while also creating a protective barrier that limits the penetration of antimicrobial agents (Flemming et al., 2016, Nature Reviews Microbiology). In the context of dental caries and periodontal disease, these proteins are essential for the accumulation of pathogenic biofilms and the localized production of acids or inflammatory factors (Xiao et al., 2012, JDR). Targeting these proteins offers a therapeutic strategy to disrupt biofilm formation or enhance the efficacy of traditional antimicrobials without necessarily killing the bacteria, thereby reducing the selective pressure for antibiotic resistance (Koo et al., 2017, Nature Reviews Microbiology). Current research focuses on small molecule inhibitors of Gtfs and matrix-degrading enzymes to manage oral health more effectively.

Other names
Extracellular polymeric substance proteinsDental plaque matrix proteinsBiofilm matrix proteinsOral biofilm EPS proteinsOral biofilm extracellular matrix proteins
02

Mechanism of action

Inhibition of glucosyltransferase (Gtf) and fructosyltransferase (Ftf) enzymes to prevent the synthesis of extracellular polysaccharides, enzymatic hydrolysis of existing matrix components (e.g., glucans), and competitive inhibition of adhesin-mediated bacterial binding to the salivary pellicle.

03

Biological functions

Cell-cell adhesionOther
04

Disease associations

InfectionInflammationOther
05

Safety considerations

Disruption of the commensal oral microbiotaLocal mucosal irritationExtrinsic tooth stainingPotential for antimicrobial resistance development
06

Interacting drugs

Chlorhexidine

6 more in the full profile.

07

Biomarkers

Glucan concentrationGlucosyltransferase activitySalivary adhesin levels

Beyond the preview

Go deeper on Oral biofilm extracellular matrix protein (EPS protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral biofilm extracellular matrix protein (EPS protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call